• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人脐带间充质干细胞在体外和体内均可分泌胰岛素。

Human umbilical cord-derived mesenchymal stem cells can secrete insulin in vitro and in vivo.

作者信息

Boroujeni Zahra Niki, Aleyasin Ahmad

机构信息

National Institute of Genetic Engineering and Biotechnology, Tehran, Iran.

出版信息

Biotechnol Appl Biochem. 2014 Mar-Apr;61(2):82-92. doi: 10.1002/bab.1127. Epub 2014 Mar 20.

DOI:10.1002/bab.1127
PMID:23725211
Abstract

Diabetes mellitus is characterized by autoimmune destruction of pancreatic beta cells, leading to decreased insulin production. Differentiation of mesenchymal stem cells (MSCs) into insulin-producing cells offers novel ways of diabetes treatment. MSCs can be isolated from the human umbilical cord tissue and differentiate into insulin-secreting cells. Human umbilical cord-derived stem cells (hUDSCs) were obtained after birth, selected by plastic adhesion, and characterized by flow cytometric analysis. hUDSCs were transduced with nonintegrated lentivirus harboring PDX1 (nonintegrated LV-PDX1) and was cultured in differentiation medium in 21 days. Pancreatic duodenum homeobox protein-1 (PDX1) is a transcription factor in pancreatic development. Significant expressions of PDX1, neurogenin3 (Ngn3), glucagon, glucose transporter2 (Glut2), and somatostatin were detected by quantitative RT-PCR (P < 0.05). PDX1 and insulin proteins were shown by immunocytochemistry analysis. Insulin secretion of hUDSCs(PDX1+) in the high-glucose medium was 1.8 μU/mL. They were used for treatment of diabetic rats and could decrease the blood glucose level from 400 mg/dL to a normal level in 4 days. In conclusion, our results demonstrated that hUDSCs are able to differentiate into insulin-producing cells by transduction with nonintegrated LV-PDX1. These hUDSCs(PDX1+) have the potential to be used as a viable resource in cell-based gene therapy of type 1 diabetes.

摘要

糖尿病的特征是胰腺β细胞发生自身免疫性破坏,导致胰岛素分泌减少。间充质干细胞(MSCs)向胰岛素分泌细胞的分化为糖尿病治疗提供了新途径。MSCs可从人脐带组织中分离出来,并分化为胰岛素分泌细胞。人脐带来源的干细胞(hUDSCs)在出生后获得,通过塑料贴壁法进行筛选,并通过流式细胞术分析进行鉴定。用携带PDX1的非整合慢病毒(非整合LV-PDX1)转导hUDSCs,并在分化培养基中培养21天。胰腺十二指肠同源盒蛋白-1(PDX1)是胰腺发育中的一种转录因子。通过定量RT-PCR检测到PDX1、神经源性分化因子3(Ngn3)、胰高血糖素、葡萄糖转运蛋白2(Glut2)和生长抑素的显著表达(P < 0.05)。通过免疫细胞化学分析显示了PDX1和胰岛素蛋白。hUDSCs(PDX1+)在高糖培养基中的胰岛素分泌量为1.8 μU/mL。它们被用于治疗糖尿病大鼠,并能在4天内将血糖水平从400 mg/dL降至正常水平。总之,我们的结果表明,hUDSCs通过用非整合LV-PDX1转导能够分化为胰岛素分泌细胞。这些hUDSCs(PDX1+)有潜力作为1型糖尿病基于细胞的基因治疗中的一种可行资源。

相似文献

1
Human umbilical cord-derived mesenchymal stem cells can secrete insulin in vitro and in vivo.人脐带间充质干细胞在体外和体内均可分泌胰岛素。
Biotechnol Appl Biochem. 2014 Mar-Apr;61(2):82-92. doi: 10.1002/bab.1127. Epub 2014 Mar 20.
2
Differentiation of PDX1 gene-modified human umbilical cord mesenchymal stem cells into insulin-producing cells in vitro.体外诱导 PDX1 基因修饰的人脐带间充质干细胞分化为胰岛素分泌细胞。
Int J Mol Med. 2011 Dec;28(6):1019-24. doi: 10.3892/ijmm.2011.774. Epub 2011 Aug 11.
3
Derivation of islet-like cells from mesenchymal stem cells using PDX1-transducing lentiviruses.利用 PDX1 转导慢病毒从间充质干细胞中诱导产生胰岛样细胞。
Biotechnol Appl Biochem. 2012 May-Jun;59(3):205-12. doi: 10.1002/bab.1013. Epub 2012 May 10.
4
Insulin producing cells established using non-integrated lentiviral vector harboring PDX1 gene.使用携带 PDX1 基因的非整合慢病毒载体建立的胰岛素分泌细胞。
World J Stem Cells. 2013 Oct 26;5(4):217-28. doi: 10.4252/wjsc.v5.i4.217.
5
Expression of Pdx1 mediates differentiation from mesenchymal stem cells into insulin-producing cells.Pdx1 的表达介导间充质干细胞向胰岛素分泌细胞的分化。
Mol Biol Rep. 2010 Dec;37(8):4023-31. doi: 10.1007/s11033-010-0061-y. Epub 2010 Mar 21.
6
Transplantation of differentiated umbilical cord mesenchymal cells under kidney capsule for control of type I diabetes in rat.将分化的脐带间充质细胞移植到大鼠肾被膜下以控制I型糖尿病
Tissue Cell. 2015 Aug;47(4):395-405. doi: 10.1016/j.tice.2015.04.008. Epub 2015 May 21.
7
[Induced differentiation of human umbilical cord mesenchymal stem modified by cells Pdx1gene into islet beta-like cells in vitro].[Pdx1基因修饰的人脐带间充质干细胞体外诱导分化为胰岛β样细胞]
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi. 2011 Dec;28(6):1175-80, 1206.
8
Generation of insulin-producing cells from human bone marrow mesenchymal stem cells by genetic manipulation.通过基因操作从人骨髓间充质干细胞生成胰岛素分泌细胞。
Stem Cells. 2007 Nov;25(11):2837-44. doi: 10.1634/stemcells.2007-0164. Epub 2007 Jul 5.
9
In vitro cultivation of islet-like cell clusters from human umbilical cord blood-derived mesenchymal stem cells.从人脐带血来源的间充质干细胞体外培养胰岛样细胞簇。
Transl Res. 2008 Jun;151(6):293-302. doi: 10.1016/j.trsl.2008.03.003. Epub 2008 Apr 28.
10
Transplantation of insulin-producing cells derived from umbilical cord stromal mesenchymal stem cells to treat NOD mice.脐带基质间充质干细胞来源的胰岛素分泌细胞移植治疗 NOD 小鼠。
Cell Transplant. 2011;20(3):455-66. doi: 10.3727/096368910X522270. Epub 2010 Aug 18.

引用本文的文献

1
hUCMSCs carrying exenatide prevent T1DM by improving intestinal microflora composition and islet tissue damage repair.携带 exenatide 的 hUCMSCs 通过改善肠道微生物群落组成和胰岛组织损伤修复来预防 T1DM。
Mol Med. 2022 Dec 13;28(1):155. doi: 10.1186/s10020-022-00526-0.
2
Human Umbilical Cord Mesenchymal Stem Cells: Current Literature and Role in Periodontal Regeneration.人脐带间充质干细胞:当前文献及在牙周再生中的作用。
Cells. 2022 Mar 30;11(7):1168. doi: 10.3390/cells11071168.
3
Tissue Engineering and Regenerative Medicine in Iran: Current State of Research and Future Outlook.
伊朗的组织工程与再生医学:研究现状与未来展望
Mol Biotechnol. 2015 Jul;57(7):589-605. doi: 10.1007/s12033-015-9865-2.
4
Stem cell treatment for type 1 diabetes.干细胞治疗 1 型糖尿病。
Front Cell Dev Biol. 2014 Mar 20;2:9. doi: 10.3389/fcell.2014.00009. eCollection 2014.
5
Putative mesenchymal stem cells isolated from adult human ovaries.从成年女性卵巢中分离出的假定间充质干细胞。
J Assist Reprod Genet. 2014 Aug;31(8):959-74. doi: 10.1007/s10815-014-0254-8. Epub 2014 May 21.
6
The potential of cell-based therapy for diabetes and diabetes-related vascular complications.基于细胞的疗法治疗糖尿病及糖尿病相关血管并发症的潜力。
Curr Diab Rep. 2014 Mar;14(3):469. doi: 10.1007/s11892-013-0469-6.